Susquehanna International Group, LLP Rocket Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$20.66 - $26.72 $1.25 Million - $1.62 Million	-60,600 Reduced 81.45%	13,800 $297,000
Q1 2024 May 07, 2024	SELL	$26.16 - $30.74 $104,640 - $122,960	-4,000 Reduced 5.1%	74,400 $2 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $892,696 - $1.7 Million	53,200 Added 211.11%	78,400 $2.35 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $6,028 - $9,620	400 Added 1.61%	25,200 $516,000
Q2 2023 Aug 11, 2023	BUY	$16.59 - $23.6 $101,199 - $143,960	6,100 Added 32.62%	24,800 $492,000
Q1 2023 May 16, 2023	SELL	$15.79 - $22.6 $288,957 - $413,580	-18,300 Reduced 49.46%	18,700 $320,000
Q4 2022 Feb 14, 2023	SELL	$15.5 - $22.76 $2.1 Million - $3.08 Million	-135,400 Reduced 78.54%	37,000 $724,000
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $2 Million - $2.98 Million	162,000 Added 1557.69%	172,400 $2.75 Million
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $70,048 - $146,432	-8,800 Reduced 45.83%	10,400 $143,000
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $63,066 - $112,631	2,300 Added 13.61%	19,200 $574,000
Q2 2021 Aug 11, 2021	SELL	$39.41 - $47.25 $1.26 Million - $1.51 Million	-32,000 Reduced 65.44%	16,900 $749,000
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $1.99 Million - $3.03 Million	-45,900 Reduced 48.42%	48,900 $2.17 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $1.95 Million - $4.98 Million	83,600 Added 746.43%	94,800 $5.2 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $393,600 - $548,928	-19,200 Reduced 63.16%	11,200 $256,000
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $243,756 - $413,763	18,300 Added 151.24%	30,400 $636,000
Q1 2020 May 15, 2020	BUY	$9.71 - $25.11 $2,913 - $7,533	300 Added 2.54%	12,100 $169,000
Q4 2019 Feb 14, 2020	SELL	$11.07 - $24.23 $46,494 - $101,766	-4,200 Reduced 26.25%	11,800 $269,000
Q3 2019 Nov 14, 2019	BUY	$10.85 - $14.78 $64,015 - $87,202	5,900 Added 58.42%	16,000 $186,000
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.81 $34,500 - $45,563	-2,300 Reduced 18.55%	10,100 $152,000
Q1 2019 May 15, 2019	BUY	$13.45 - $19.01 $166,780 - $235,724	12,400 New	12,400 $217,000
Q4 2018 Feb 14, 2019	SELL	$11.21 - $23.53 $105,374 - $221,182	-9,400 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$18.5 - $25.49 $33,300 - $45,882	-1,800 Reduced 16.07%	9,400 $231,000
Q2 2018 Aug 14, 2018	SELL	$14.58 - $23.0 $435,942 - $687,700	-29,900 Reduced 72.75%	11,200 $220,000
Q1 2018 May 15, 2018	BUY	$11.68 - $19.19 $480,048 - $788,709	41,100 New	41,100 $771,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$208 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$132 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$72.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$65.1 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$52.8 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $890M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account